ACRV
Acrivon Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$74.90M
P/E Ratio
—
EPS
$-2.00
Beta
2.02
52W High
$3.56
52W Low
$1.05
50-Day MA
$1.73
200-Day MA
$1.84
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of precision cancer medicines. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-80.93M |
| Operating Margin | 0.00% |
| Return on Equity | -60.40% |
| Return on Assets | -36.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.46 |
| Price-to-Book | 0.78 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $42.80M |
| Float | $27.97M |
| % Insiders | 15.40% |
| % Institutions | 47.04% |
Historical Volatility
HV 10-Day
79.38%
HV 20-Day
78.46%
HV 30-Day
78.89%
HV 60-Day
82.80%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.50 target)
3
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026